Yusuf Hamied

Scientist, Entrepreneur

Indian Vilnius, Lithuania (formerly Wilno, Poland)

Quick Info

ProfessionScientist, Entrepreneur
NationalityIndian
Date of Birth25/07/1936
Age89 years
BirthplaceVilnius, Lithuania (formerly Wilno, Poland)

Do you like Yusuf Hamied?

You can vote only once.

Bio/Wiki

Full nameYusuf Khwaja Hamied

Physical Stats & More

Height165 cm (5' 5")
Eye ColorBlack
Hair ColorSalt and Pepper

Educational Qualification(s)

SchoolThe Cathedral and John Connon School, Mumbai
College/University
  • St. Xavier’s College, Mumbai
  • Christ's College, University of Cambridge
Educational Qualifications
  • Bachelors of Arts at St. Xavier’s College, Mumbai
  • Masters of Arts (1954) and Ph.D. (steroid chemistry, applied organic chemistry) at Christ's College, University of Cambridge (1960)
  • Honorary Degree by the University of Cambridge (2014)
  • Bachelor's in Chemistry (1957) from Christ's College, University of Cambridge
  • Ph.D. in Chemistry from Christ's College, University of Cambridge
  • Bachelor of Arts in Chemistry (1957) from Christ's College, University of Cambridge
  • Ph.D. in Organic Chemistry (1960) from Christ's College, University of Cambridge under Nobel Laureate Lord Alexander Todd
  • Honorary Doctorate from University of Cambridge (2014)
  • Honorary Fellowship, Christ's College, Cambridge (2004)
  • Honorary Fellowship, Royal Society of Chemistry (2012)
  • Honorary Doctorate of Science, Indian Institute of Technology, Mumbai (2017)

Personal Life

ReligionIslam

Relationships & More

Marital StatusMarried
Marriage DateYear, 1954
SpouseFarida Yusuf Hamied

Family

FatherKhwaja Abdul Hamied (founder of Cipla, India's oldest pharmaceutical company)
MotherLubna Derczanska
Siblings
  • Mustafa Khwaja Hamied (non-executive vice-chairman of Cipla)
  • Sophie Ahmed
SpouseFarida Yusuf Hamied (director of Mn Rajkumar Garments Private Limited and Alps Remedies Private Limited)
ChildrenNo children

Career

Award and Honors
  • 2005: Padma Bhushan (India's third highest civilian honour by the Government of India)
  • 2012: The 'CNN-IBN Indian of the Year' award in the business category from CNN-IBN
  • 2013: One of India's '25 Greatest Global Living Legends' by NDTV
  • 2013: Included in the list of richest Indians by Forbes magazine
  • 2016: The Forbes India Lifetime Achievement Award
  • 2019: Honorary Fellow of the Royal Society, London
  • 2011: BioSpectrum Asia Pacific Bioscience Industry Life Time Achievement Award
  • 2004: Honorary Fellowship, Christ's College, Cambridge
  • 2012: CNN-IBN Indian of the Year award in the business category
  • 2012: Honorary Fellowship, Royal Society of Chemistry
  • 2013: One of India's '25 Greatest Living Legends' by NDTV
  • 2014: Honorary Doctorate, University of Cambridge
  • 2016: First Alumni Medal, Department of Chemistry, Cambridge University
  • 2016: Forbes India Lifetime Achievement Award
  • 2017: Public Health Hero award from Columbia University, USA
  • 2017: Honorary Doctorate of Science, Indian Institute of Technology, Mumbai
  • 2019: Fellow of the Royal Society, London (FRS)
Joined Cipla1960 (as officer-in-charge of research and development)
Managing Director1976–2013
Chairman1989–present (Non-Executive Chairman since 1 April 2013)
Key AchievementIn September 2000, announced ability to produce AIDS drug cocktails for less than $1 per day, later reduced to 20 cents per day, making treatment accessible to millions in developing countries
Current PositionNon-Executive Chairman of Cipla Ltd.
Key Achievements
  • Instrumental in persuading the Indian government to change patent law in 1972, enabling manufacture of generic drugs
  • Founded the Indian Drug Manufacturers Association in 1961
  • In 2000, announced ability to produce AIDS drug cocktails (Triomune) for less than $1 per day, later reduced to 20 cents per day
  • Made life-saving medicines accessible to millions in developing countries regardless of ability to pay
  • Over six million people in the developing world now receive AIDS treatment through Cipla's affordable generic drugs
  • Cipla operates with over 2,000 generic products across 183 countries

Some Lesser Known Facts

1. Yusuf Khwaja Hamied is an Indian scientist and a prominent businessman.
2. He serves as the chairman of Cipla, an Indian company specializing in generic medicines.
3. Yusuf Hamied is recognized for advocating against large western drug companies to increase access to affordable AIDS medications and essential drugs for disadvantaged populations in developing nations.
4. The Cipla company was founded in 1935 by Yusuf Hamied's father, Khwaja Abdul Hamied.
5. Yusuf Hamied is esteemed as a fellow member of the Indian National Science Academy.
6. He obtained his PhD in organic chemistry in 1960 from the University of Cambridge under the tutelage of Nobel laureate Lord Alexander Todd.
7. He obtained his PhD in organic chemistry from the University of Cambridge under the tutelage of Nobel laureate Lord Alexander Todd.
8. Under his leadership, Cipla made Triomune (first-line anti-retroviral therapy for AIDS) available at less than $1 per patient per day in 2001, hailed as a major breakthrough in the fight against AIDS.
9. More than six million people in the developing world now receive AIDS treatment through Cipla's affordable generic drugs, up from little more than 2,000 in 2001.
10. Cipla operates with over 2,000 generic products made available across 183 countries under his leadership.
11. He has been characterized as a modern-day Robin Hood for his efforts to eradicate AIDS in the developing world and provide life-saving medicines regardless of patients' ability to pay.
12. He serves as the non-executive chairman of Cipla, an Indian company specializing in generic medicines.
13. Yusuf Hamied is recognized for advocating against large Western pharmaceutical companies to increase access to affordable AIDS medications and essential drugs for disadvantaged populations in developing nations.
14. Cipla was founded in 1935 by Yusuf Hamied's father, Khwaja Abdul Hamied.
15. He is an elected fellow of the Indian National Science Academy.
16. He obtained his Ph.D. in organic chemistry in 1960 from the University of Cambridge under the tutelage of Nobel Laureate Lord Alexander Todd.
17. He pioneered the commercial synthesis of anti-retroviral drugs by developing patent non-infringing processes.
18. He has been instrumental in driving successful academic collaboration between India and Cambridge University.
Information on this page is collected from public sources and may not be 100% accurate. Report an error
Scroll to Top